New test could tell stomach cancer patients if chemo will work

This study aims to create a tool that uses genetic information from tumor tissue to predict whether a stomach cancer patient will respond well to chemotherapy after surgery. By analyzing RNA splicing patterns with machine learning, researchers hope to identify patients who are less likely to benefit, allowing doctors to consider alternative treatments. The study will involve 329 participants with stage II or III gastric cancer who have already had surgery and received standard chemotherapy.